From the *Service de Biophysique et Médecine Nucléaire, †Unité de Neuro-vasculaire, and ‡Service de Radiologie, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg; and §Université de Strasbourg/CNRS, UMR 7237, Strasbourg, France.
Clin Nucl Med. 2014 Mar;39(3):e239-40. doi: 10.1097/RLU.0b013e318286bd6f.
We report imaging findings during, between, and after 2 stroke-like episodes in a 45-year-old woman with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome with an A32243G mitochondrial mutation 6 years before. In November 2010, for a first episode, she showed mixed aphasia with logorrhea, disinhibition, agitation, euphoria, and a large left temporoparietal lesion. Symptomatology progressively regressed under L-arginine treatment. She was readmitted in June 2011 for a second episode with great anxiety, disorientation, impaired face recognition, worsening mixed aphasia, and a new right temporal lesion. After additional L-carnitine treatment, she remained without relapse for 14 months.
我们报告了一位 45 岁女性的两起类似中风发作期间、之间和之后的影像学发现,该女性患有线粒体肌病、脑病、乳酸酸中毒和中风样发作(MELAS)综合征,其线粒体突变 A32243G 早在 6 年前就已存在。2010 年 11 月,第一次发作时,她出现混合性失语,表现为言语过多、抑制障碍、激动、欣快,以及左颞顶叶大病灶。在 L-精氨酸治疗下,症状逐渐消退。2011 年 6 月,她因第二次发作再次入院,表现为严重焦虑、定向障碍、面部识别能力受损、混合性失语加重,以及新的右颞叶病灶。在接受额外的左旋肉碱治疗后,她在 14 个月内没有复发。